Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review

BACKGROUND: The combination of immune checkpoint inhibitors (ICIs) and thoracic radiotherapy (TRT) has shown significant clinical activity in patients with non-small cell lung cancer (NSCLC). However, the currently available data on adverse events (AEs) were derived from a small subset of patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Butuo, Jiang, Chao, Pang, Linlin, Zou, Bing, Ding, Mingjun, Sun, Xindong, Yu, Jinming, Wang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042254/
https://www.ncbi.nlm.nih.gov/pubmed/33859637
http://dx.doi.org/10.3389/fimmu.2021.627197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042254/
https://www.ncbi.nlm.nih.gov/pubmed/33859637
http://dx.doi.org/10.3389/fimmu.2021.627197

Ejemplares similares